Johnson & Johnson diskutieren
Johnson & Johnson
WKN: 853260 / Symbol: JNJ / Name: Johnson & Johnson / Aktie / Pharmazeutika / Large Cap /
178,12 €
-2,37 %
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at TD Cowen from $195.00 to $185.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $175.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $175.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target raised by analysts at Royal Bank of Canada from $175.00 to $178.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target raised by analysts at Royal Bank of Canada from $178.00 to $181.00. They now have an "outperform" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target raised by analysts at Citigroup Inc. from $180.00 to $185.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $190.00 price target on the stock.
Ratings data for JNJ provided by MarketBeat
Johnson & Johnson (NYSE: JNJ) had its price target lowered by analysts at Citigroup Inc. from $185.00 to $175.00. They now have a "buy" rating on the stock.
Ratings data for JNJ provided by MarketBeat
Neueste Beiträge
BTIG_Research in Workday, Inc. diskutieren